STOAF III SciTech and Almi Invest have jointly invested 3.8 MSEK in Developeration AB to further develop PexyEazy®, an innovative surgical instrument for hemorrhoid treatment.

Target Information

Developeration AB, based in Stockholm, has established itself as a pioneering company in the medical device sector with the creation of PexyEazy®, a state-of-the-art single-use surgical instrument specifically designed for the treatment of hemorrhoids. This innovative device provides a surgical solution that does not require patient anesthesia and allows for a significantly reduced operational time of merely 10 minutes.

This advancement not only enhances patient comfort and reduces pain but also optimizes operational efficiency for healthcare facilities by allowing them to conduct up to three times more procedures per day, all while achieving cost savings of up to 70 percent per operation.

Industry Overview

The healthcare industry in Sweden continues to thrive, with a strong emphasis on innovation and the development of advanced medical technologies. The country has made substantial investments in healthcare solutions aimed at enhanc